|
10/6/2016
The Commission placed this coverage guidance on "passive monitoring." Interested stakeholders can request a review by contacting herc.info@odhsoha.oregon.gov.
|
|
1/8/2015
HERC reviewed and approved the draft coverage guidance and related
Prioritized List changes as presented in the meeting materials.
|
|
11/13/2014
VbBS reviewed the draft coverage guidance and recommended prioritization changes. See meeting materials for recommendations.
|
|
9/4/2014
The EbGS reviewed public comments and heard public testimony on the draft coverage guidance, made revisions, and referred it to the VbBS and HERC for prioritization changes and approval. The VbBS will review the draft coverage guidance at its meeting on 11/13/2014.
|
|
6/20/14 to 8 a.m. 7/22/2014
The draft coverage guidance has been posted for a 30-day comment period. Rules for offering public comment are posted on our Coverage Guidance Open for Comment page.
|
|
5/5/2014
EbGS will discuss this topic at its June 5, 2014 meeting. Sources are:
Al-Khatib, S.M., Allen Lapointe, N., Chatterjee, R., Crowley, M.J., Dupre, M.E., Kong, D.F., et al. (2013). Treatment of atrial fibrillation. Comparative Effectiveness Review 119. (Prepared by the Duke Evidence-based Practice Center under Contract No. 290-2007-10066-I.) AHRQ Publication No.13-EHC095-EF. Rockville, MD: Agency for Healthcare Research and Quality. Retrieved from www.effectivehealthcare.ahrq.gov/reports/final.cfmChen, H.S., Wen, J.M., Wu, S.N., & Liu, J.P. (2012). Catheter ablation for paroxysmal and persistent atrial fibrillation. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD007101. DOI: 10.1002/14651858.CD007101.pub2. Retrieved from http://summaries.cochrane.org/CD007101/catheter-ablation-would-be-an-alternative-to-inhibit-recurrence-of-paroxysmal-or-persistent-atrial-fibrillation (link no longer valid) Hashimoto, R.E., Raich, A., Junge, M., & Skelly, A. (2013). Catheter ablation procedures for supraventricular tachyarrhythmia, including atrial flutter & atrial fibrillation. Olympia, WA: Washington State Health Care Authority Health Technology Assessment Program. Retrieved from http://www.hca.wa.gov/hta/Pages/Forms/HTA_Findings.aspx (link no longer valid) January, C.T., Wann, L.S., Alpert, J.S., Calkins, H., Cleveland, Jr, J.C., Cigarroa, J.E., et al. (2014). 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 129. doi:10.1161/CIR.0000000000000041. Retrieved from http://circ.ahajournals.org/content/early/2014/03/27/CIR.0000000000000041.citation (link no longer valid)
|
|
5/16/2019
VbBS will address this topic at its August 8, 2019 meeting; no coverage guidaance is forthcoming.
|
|
3/9/2017
The draft scope statement was discussed at the 2/16/2017 HTAS meeting. The topic was considered for selection at the March 9, 2017 HERC meeting.
|
|
2/16/2017
HTAS will review the draft scope statement recommendations at its meeting and may refer them to HERC for consideration in topic selection.
|
|
1/27/2017-2/6/2017
Scope statement posted for public comment date range 1/27/2017-2/6/2017, 8:00 am
This
topic is under consideration for creation of a new coverage guidance.
HERC will decide on next topics for coverage guidance development at its
March 9, 2017 HERC meeting.
|
|
3/9/2017
The Health Evidence Review Commission reaffirmed the previously approved coverage guidance. It is now on "passive monitoring." Stakeholders can contact staff at herc.info@state.or.us for consideration of updating this coverage guidance.
|
|
9/1/2016
EbGS reviewed the draft scope statement.
|
|
8/9/2012
The HERC reviewed the draft coverage guidance as referred by the EbGS on August 2, 2012 and approved it.
|
|
5/3/2012
The EbGS reviewed the initial draft coverage guidance on May 3, 2012.
|
|
10/6/2016
The Commission placed this coverage guidance on "passive monitoring." Interested stakeholders can request a review by contacting herc.info@dhsoha.state.or.us.
|
|
1/8/2015
VbBS reviewed and made Prioritized List change recommendations, which included changes from the meeting materials. HERC approved the draft coverage guidance and related Prioritized List changes as modified during the meeting.
|
|
11/24/2014
HTAS reviewed the draft coverage guidance. HERC and VbBS will review the draft coverage guidance and potential associated potential prioritization changes at their meetings 1/8/2015.
|
|
9/25/2014 to 8 a.m. 10/27/2014
The draft coverage guidance has been posted for a 30-day comment period. Rules for offering public comment are posted on our Coverage Guidance Open for Comment page.
|
|
8/22/2014
The title for the coverage guidance previously called PET/CT/Radionuclide in Staging for Prostate Cancer has been changed. The new title is Advanced Imaging in Staging of Prostate Cancer.
|
|
8/13/2014
The source report has been posted for this topic:
Trusted source:
National Institute for Health and Clinical Excellence, (2014). Prostate Cancer: diagnosis and treatment. London: National Institute for Health and Clinical Excellence. Retrieved 6/25/14 from http://guidance.nice.org.uk/CG175/Guidance
|
|
5/17/2018
The coverage guidance Prostatic Urethral Lifts for Benign Prostatic Hypertrophy was approved. It supersedes a portion of this coverage guidance and recommends coverage for prostatic urethral lifts.
|
|
3/26/2018
A new coverage guidance on Prostatic Urethral Lifts for Benign Prostatic Hypertrophy is under development. When approved, it will supersede the portions of this coverage guidance related to Prostatic Urethral Lifts.
|
|
10/6/2016
The Commission placed this coverage guidance on "passive monitoring." Interested stakeholders can request a review by contacting herc.info@dhsoha.state.or.us.
|
|
3/12/2015
HERC reviewed and approved the draft coverage guidance and related Prioritized List changes as presented in the meeting materials.
|
|
2/26/2015
HERC will review the draft coverage guidance on 3/12/2015.
|
|
2/23/2015
HTAS reviewed public comment and referred the draft coverage guidance to the VbBS and HERC.
|
|
1/23/2015
New sources:
Ahyai, S. A., Gilling, P., Kaplan, S. A., Kuntz, R. M., Madersbacher, S., Montorsi, F, et al. (2010). Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. European urology,58(3), 384-397. doi:10.1016/j.eururo.2010.06.005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0029840/
Bachmann, A.,Tubaro, A., Barber, N., d’Ancona, F., Muir, G., Witzsch, U., et al. (2014). 180-W XPS GreenLight Laser Vaporization Versus Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 6-Month Safety and Efficacy Results of a European Multicentre Randomised Trial – The GOLIATH Study. European urology, 65, 931-42. doi: 10.1016/j.eururo.2013.10.040.
Cornu, J. N., Ahyai, S., Bachmann, A., de la Rosette, J., Gilling, P., Gratzke, C., et al. (2014). A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. European urology. doi: 10.1016/j.eururo.2014.06.017.
Lee, S. W., Choi, J. B., Lee, K. S., Kim, T. H., Son, H., Jung, T. Y., ... & Kim, J. C. (2013). Transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement: a quality and meta-analysis.International neurourology journal, 17(2), 59-66. doi: 10.5213/inj.2013.17.2.59.Retrieved from http://synapse.koreamed.org/Synapse/Data/PDFData/1092INJ/inj-17-59.pdf (link no longer valid)
|
|
11/24/2014
HTAS reviewed the draft coverage guidance, made revisions and posted it for public comment, 12/4/2014 to 8:00 a.m. 12/26/2014.
|
|
11/20/2014
Updated draft coverage guidance posted as handout for the 11/24/2014 HTAS meeting.
|
|
9/26/2014 to 8 a.m. 10/28/2014
The draft coverage guidance has been posted for a 30-day comment period. Rules for offering public comment are posted on our Coverage Guidance Open for Comment page.
|
|
8/13/2014
Sources have been posted for this topic:
Trusted sources:
National Institute for Health and Clinical Excellence, (2010). Management of lower urinary tract symptoms in men. London: National Institute for Health and Clinical Excellence. Retrieved from http://www.nice.org.uk/guidance/cg97
National Institute for Health and Clinical Excellence, (2013). Interventional procedure guidance 453: Prostate artery embolisation for benign prostatic hyperplasia. London: National Institute for Health and Clinical Excellence. Retrieved from www.nice.org.uk/guidance/ipg453
National Institute for Health and Clinical Excellence, (2014). Interventional procedure guidance 475: Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia. Retrieved from www.nice.org.uk/guidance/ipg475 (3/23/16 note: Link removed; no longer valid)
Hatem, M., Sandall, J., Devane, D., Soltani, H., & Gates, S. (2008). Midwife-led versus other models of care for childbearing women. Cochrane Database of Systematic Reviews, 4(10).
|
|
7/28/2014
Topic name changed from "Surgical Treatment of Lower Urinary Tract Symptoms in Men" to "Alternatives to Transurethral Resection of the Prostate."
|
|
6/24/2014
The HTAS will discuss the initial draft coverage guidance at its meeting on 9/22/2014 at 1 p.m.
Initial sources for the report are:
National Institute for Health and Clinical Excellence, (2013). Interventional procedure guidance 453: Prostate artery embolisation for benign prostatic hyperplasia. London: National Institute for Health and Clinical Excellence. Retrieved from www.nice.org.uk/nicemedia/live/13705/63679/63679.pdf (link not active 9/11/2015) National Institute for Health and Clinical Excellence, (2014). Interventional procedure guidance 475: Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia. Retrieved from www.nice.org.uk/nicemedia/live/13967/66323/66323.pdf (link not active 8/17/2015) National Institute for Health and Clinical Excellence, (2010). Management of lower urinary tract symptoms in men. London: National Institute for Health and Clinical Excellence. Retrieved from http://www.nice.org.uk/guidance/cg97 (link no longer valid)
|
|
9/4/2014
EbGS made conforming changes to the evidence evaluation as requested by HERC on 8/14/2014. Changes to coverage under the Oregon Health Plan will be effective January 1, 2015.
|
|
8/14/2014
The Health Evidence Review Commission reviewed and approved the evidence evaluation and associated prioritization and guideline note changes, but also referred the evidence evaluation back to EbGS for alignment with parity rules. Reviewed Evidence Evaluation and Prioritized List Changes
|
|
6/12/2014
The Value-based benefits Subcommittee reviewed the draft evidence
evaluation and approved guideline note changes for the Prioritized List.
|
|
5/8/2014
The Value-based Benefits subcommittee discussed the draft evaluation of
evidence at its meeting and deferred a decision until its next meeting,
which will occur June 12, 2014.
|
|
5/6/2014
Posted current draft evaluation of evidence, including changes from 4/24/2014 EbGS meeting.
|
|
4/24/2014
The EbGS made revisions to the draft evaluation of evidence and referred
it to the Health Evidence Review Commission. A revised draft will be
posted as soon as possible.
|
|
3/20/2014
The EbGS began its review of public comment but did not approve the
draft evidence evaluation. The subcommittee will continue its review of
public comments and complete its evaluation of the evidence on
4/24/2014.
|
|
2/18/2014
Citation:
Therapies for children with autism spectrum disorder –
Behavioral interventions update. Draft Comparative Effectiveness Review.
Rockville, MD: Agency for Healthcare Research and Quality. Retrieved
January 27, 2014, from http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayProduct&productID=1845
|
|
2/12/2014
As a result of the cancellation of the 2/6/14 EbGS meeting, a new
replacement meeting has been scheduled for 3/20/2014 at 2 p.m. In
addition, the EbGS meeting previously scheduled for 4/3/2014 has been
rescheduled to 4/24/2014. Locations for both meetings are yet to be
determined.
|
|
2/6/2014
EbGS meeting cancelled due to inclement weather and unforeseen circumstances.
|
|
12/16/2013
Public comment period ended at 8:00 am.
|
|
11/14/13 - OPEN FOR PUBLIC COMMENT 11/14/13-12/16/13 (at 8 a.m.)
The Draft Evaluation of Evidence has been posted for a 30-day comment period. Rules for offering public comment will follow those listed on our Coverage Guidance Open for Comment page.
|
|
11/7/2013
The EbGS continued the discussion of the draft Evaluation of Evidence
and heard testimony from appointed experts and members of the public.
The subcommittee voted to revise the draft and post it for a 30-day
public comment period. The revised draft will posted by next week, and
the subcommittee plans to review written public comments at the EbGS
meeting 2/6/2014.
|
|
10/4/2013
HERC recently received permission to post these references
to evidence sources used in developing the Evaluation of Evidence. They
will be added as an appendix to the next version of the Evaluation of Evidence when it is posted.
|
|
9/12/2013
The EbGS reviewed the draft Evaluation of Evidence, heard public testimony and will continue discussion at its 11/7/13 meeting.
Applied Behavior Analysis for Autism Spectrum Disorders Brief.pdf
Applied Behavior Analysis for Autism Spectrum Disorders DRAFT for EbGS Meeting Materials 9-12-2013.pdf
Sources
Invited comments for the 9/12/13 EbGS meeting: Presentations from: Green, Reichow, Hagopian, Legaard
|
|
8/8/2013
HERC directed EbGS to review the evidence.
|
|
3/9/2017
The Health Evidence Review Commission reaffirmed the previously approved coverage guidance. It is now on "passive monitoring." Stakeholders can contact staff at herc.info@state.or.us for consideration of updating this coverage guidance.
|